Navigation Links
AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US
Date:9/18/2009

TUSTIN, Calif., Sept. 18 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major assets in China, announced today its stockholders have approved by verbal consent the name change and rebranding of the Company as "Radient Pharmaceuticals Corporation". The new ticker symbol on the New York Stock Exchange Alternext US will be "RPC". The Company has filed an amendment to its 'Articles of Incorporation' to implement this change effective prior to the open of the markets on Friday, September 25, 2009.

AMDL believes this name change more accurately reflects the Company's core business and assets given its most recent news announcing the monetization strategy for the Company's China-based subsidiary Jade Pharmaceuticals Inc.; formation of the newly formed, wholly-owned subsidiary AMDL Diagnostics Inc. (ADI) focused on the commercialization of AMDL's proprietary Onko-Sure(TM) In Vitro Diagnostic (IVD) cancer test; and introduction of the new Elleuxe(TM) high-end skin care line.

"Approval of our new name and ticker symbol is a milestone event for our Company," stated Mr. Douglas MacLellan, Chairman and CEO of Radient Pharmaceuticals. "We believe Radient Pharmaceuticals as a brand name has considerable bench strength, and clearly represents the Company's core business and market focus, particularly as it relates to the international commercialization of Onko-Sure(TM) and Elleuxe(TM). It promotes a clear, unified, and consistent brand to the global markets we are targeting with our life-changing products."

In addition to today's rebranding announcement, AMDL completed a note and warrant purchase agreement with St. George Investments, LLC in the amount of approximately $555,555 and a bridge loan with Cantone Asset Management in the amount of $58,000. For additional information, please refer
'/>"/>

SOURCE AMDL Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. LCA-Vision Announces CEO Resignation
2. Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers
3. Rigel Announces Pricing of Public Offering of 13,000,000 Shares of Common Stock
4. InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis
5. Aethlon Medical, Inc. Announces Annual Meeting Results
6. Sangamo BioSciences Announces Presentation at the UBS Global Life Sciences Conference
7. Martek Announces Addition to Its Board of Directors
8. Pervasis Therapeutics Announces $17 Million in Financing and New Board Member
9. BVGH Announces New Board Chair
10. Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target
11. Enerkem Announces Construction Start on Advanced Energy Research Facility in Edmonton, Alberta
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Dec. 14 Vermillion, Inc. (Pink ... announced William C. Wallen, Ph.D. Chief Scientific ... for IDEXX Laboratories, will be joining its ... bankruptcy plan. ,, "Bill brings more ... in diagnostics and biotechnology," said Gail Page, ...
(Date:12/14/2009)... Scientific Corporation (NYSE: BSX ) today announced ... aggregate principal amount of its senior notes under the ... of $850 million of 4.50 percent notes due January ... 2020 and $300 million of 7.375 percent notes due ... net proceeds for general corporate purposes, including prepaying its ...
(Date:12/14/2009)... ThermoFab, a US-based thermoforming company, has completed the delivery of ... sheet metal to a plastic enclosure with a smaller footprint ... ... Shirley, MA (PRWEB) December 14, 2009 -- ThermoFab, a US-based ... Flow Tester – helping Brookfield move from sheet metal to ...
(Date:12/11/2009)... 10, 2009 miRagen Therapeutics, Inc., a biopharmaceutical ... innovative microRNA-based therapeutics for cardiovascular and muscle disease, ... microRNA-206 (miR-206) plays a crucial role in the ... Gehrig,s disease) and in neuromuscular synaptic regeneration in ... 11 issue of the journal Science , ...
Breaking Biology Technology:Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2
... have invented an affordable technique that uses lasers and ... needed for new generations of microchips. , The ... times narrower than a human hair, may enable the ... applications in medicine, optical communications, computing and sensor technologies. ...
... (Nasdaq: EXEL ) announced today that Frank Karbe, ... present at the,Piper Jaffray Europe Conference at 3:40 a.m. ... 25, 2008. Mr. Karbe will discuss updates,to the company,s ... be webcast and may be accessed in the Event,Calendar ...
... Germany is on the,cutting edge in biotechnology R&D and ... located in Germany are poised to,profit from the latest ... panel, at the BIO International Convention (BIO 2008),in San ... the,panel along with the CEO of a major transatlantic ...
Other Biology Technology:Trap and zap: Harnessing the power of light to pattern surfaces on the nanoscale 2Trap and zap: Harnessing the power of light to pattern surfaces on the nanoscale 3BIO 2008: Germany on Cutting Edge in Biomanufacturing 2
(Date:12/13/2009)... The Scripps Research Institute have solved a 10-year-old ... ancient family of enzymes can have two completely ... providing guidance for understanding other molecules in the ... the protein,s possible use for combating diseases including ... published in the December 13, 2009 advance, online ...
(Date:12/11/2009)... GETTYSBURG, PAAs consumer demand for premium fruit increases, ... fruit to market. And to boost their bottom ... that can increase fruit quality while reducing labor ... by growers to produce larger, healthier fruit, is ... a significant impact on fruit production overhead, and, ...
(Date:12/11/2009)... green plants photosynthesize, absorb carbon dioxide and produce ... that photosynthesis has had on Earth. One of ... evolution of photosynthesis is Jeffrey Touchman, assistant professor ... , Oxygen, one of the by-products of photosynthesis ... (including algae and higher plants), transformed the Precambrian ...
Breaking Biology News(10 mins):Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3Horizontal string trimmer reduces labor costs, increases peach size 2'Extreme' genes shed light on origins of photosynthesis 2'Extreme' genes shed light on origins of photosynthesis 3Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 1Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 2Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 3Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 4Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 5Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 6Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 7Boys May Feel a Genetic Pull Toward Gangs 49195 1Boys May Feel a Genetic Pull Toward Gangs 49195 2New Anticoagulant Pill Works Well in Trial 49193 1New Anticoagulant Pill Works Well in Trial 49193 2New Anticoagulant Pill Works Well in Trial 49193 3
... accurately sense light governs everything from seed germination, photosynthesis ... Now, for the first time, scientists have obtained a ... detectors, a protein found in many species across life's ... structure of the protein known as phytochrome, scientists can ...
... , Chinese men are selectively switching from traditional ... dysfunction, but sticking with tradition for ailments such ... research published in Environmental Conservation. , The finding ... researchers at the advent of Viagra's commercial release ...
... and five million years ago, a massive swarm of ... and made an unlikely voyage across the Atlantic Ocean ... of researchers. , Using genetic evidence from more than ... Toronto, Arizona, Maryland, Cornell University and the U.S. Department ...
Other Biology News:Scientists map one of biology's critical light-sensing structures 2Scientists map one of biology's critical light-sensing structures 3Viagra's hidden help for wildlife 2Ancient trans-Atlantic swarm brought locusts to the New World 2
... Each glass slide in this set ... antibodies in triplicate, for a total ... house-keeping proteins as internal control. Antibodies ... as angiogenesis, apoptosis, cell cycle progression, ...
...
...
Kit for testing the ability of a compound to simulate lipolysis in cultured human adipocytes. Kit contains controls, buffers and reagents for detecting glycerol and non-esterified free fatty acids. A...
Biology Products: